Publications examine U.S. funding for global HIV/AIDS

In light of a Medecins Sans Frontieres (MSF) report calling for sustained HIV/AIDS funding, VOA News writes: "Many AIDS-related groups and activists have been calling on U.S. President Barack Obama to fulfill his funding pledges made during the presidential campaign. But are they asking too much, considering the economic downturn?" Sharonann Lynch, an HIV policy advisor for MSF, said, "PEPFAR has the opportunity to save six million lives and it shouldn't settle for three."

According to VOA News, the Obama administration says it remains committed to PEPFAR and has asked for $6.6 billion to go to the program in FY2010. PEPFAR officials have noted "that the economic crisis does figure prominently in their funding decisions," VOA News writes (De Capua, 11/5).

The Washington Post reports that in an August letter to American ambassadors, Global AIDS Coordinator Eric Goosby wrote, "The landscape around us is changing, with the need to balance a broad portfolio of global challenges at a time of financial crisis ... As a result, we need to plan for the next stage of PEPFAR's development in this context and cannot assume the dramatic funding growth of PEPFAR's early years will be repeated."

In May, Obama announced a $63 billion, six-year global health initiative "pledging to broaden the U.S. approach to global health by focusing on tropical diseases and other preventable illnesses, in addition to [HIV/]AIDS" (Brulliard, 11/6).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the mechanisms of efavirenz-induced neurotoxicity